Eldorado and Foran will host a joint conference call to discuss the Transaction on February 2, 2026, at 8:00 AM ET (5:00 AM PT). The joint conference call will be hosted by George Burns and Christian ...

Maze Therapeutics' Senior Vice President of Finance sold shares towards the end of January 2026, all while the company's stock had one of the best first-year performances of a biopharmaceutical ...

At press time, King Crypto fell by 7% in 24 hours to trade at $77,934.46. This is the lowest it has dropped to since April 2025, when a selloff happened right after U.S. President Donald Trump’s ...

Gary P is a former Goldman Sachs and New York Stock Exchange trader with decades of institutional trading experience. He ...

Fantastic returns in the past decade have propelled the S&P 500’s valuation to high levels. While investors are better served ...

Investors are increasingly souring on the United States, as illustrated by the declining dollar, the stalled stock market and rising government borrowing costs.

Globus Medical, Inc. (NYSE: GMED) recently garnered a “Buy” rating from analyst David Saxon of Needham, signaling significant upward potential for the stock. Currently priced at $90.68, the firm has ...

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on ...

Target (TGT) closed the most recent trading day at $101.74, moving -2.27% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 0.01%. Elsewhere, the Dow ...

Learn more about whether Franco-Nevada Corporation or Hudbay Minerals Inc. is a better investment based on AAII's A+ Investor ...

Inside this Jeff Zananiri’s Trade Like a Pro Bootcamp review 2026, learn what’s included, who it’s for, pricing,, and whether ...

Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Freeport-McMoRan with a target price of $67. An analyst from JP Morgan has decided to maintain their Overweight rating ...